Skip to main content

Table 2 Incidence of hypomagnesemia and hypocalcemia after treatment with cetuximab or panitumumab

From: Correlation between blood magnesium and calcium concentration in patients treated with an anti-EGFR antibody

 

Hypomagnesemia

N (%)

Hypocalcemia

N (%)

Any Grade

13 (59.1)

16 (72.7)

Grade 2

4 (18.2)

1 (4.5)

Grade 3/4

2 (9.1)

0 (0.0)